Your browser doesn't support javascript.
loading
Efficacy of ibrutinib as salvage treatment in a secondary central nervous system lymphoma (SCNSL) progressed after chemorefractory Primary Mediastinal B Cell Lymphoma (PMBCL).
Malfona, Francesco; Testi, Anna Maria; Moleti, Maria Luisa; Petrucci, Luigi; Leccisotti, Lucia; Martelli, Maurizio; Di Rocco, Alice.
Afiliación
  • Malfona F; Hematology, Department of Translational and Precision Medicine, Sapienza University, Rome, Italy.
  • Testi AM; Hematology, Department of Translational and Precision Medicine, Sapienza University, Rome, Italy.
  • Moleti ML; Hematology, Department of Translational and Precision Medicine, Sapienza University, Rome, Italy.
  • Petrucci L; Hematology, Department of Translational and Precision Medicine, Sapienza University, Rome, Italy.
  • Leccisotti L; Nuclear Medicine Unit, Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Rome.
  • Martelli M; Hematology, Department of Translational and Precision Medicine, Sapienza University, Rome, Italy.
  • Di Rocco A; Hematology, Department of Translational and Precision Medicine, Sapienza University, Rome, Italy.
Leuk Lymphoma ; 63(2): 483-486, 2022 02.
Article en En | MEDLINE | ID: mdl-34612154

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Linfoma de Células B / Linfoma de Células B Grandes Difuso / Neoplasias del Sistema Nervioso Central / Linfoma / Neoplasias del Mediastino Tipo de estudio: Diagnostic_studies Idioma: En Revista: Leuk Lymphoma Asunto de la revista: HEMATOLOGIA / NEOPLASIAS Año: 2022 Tipo del documento: Article

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Linfoma de Células B / Linfoma de Células B Grandes Difuso / Neoplasias del Sistema Nervioso Central / Linfoma / Neoplasias del Mediastino Tipo de estudio: Diagnostic_studies Idioma: En Revista: Leuk Lymphoma Asunto de la revista: HEMATOLOGIA / NEOPLASIAS Año: 2022 Tipo del documento: Article